AAF Management Ltd.

At AAF Management Ltd. we're excited to announce our investment in Uniblock's $5.2 million Seed round alongside SBI Investment, AllianceDAO, CoinSwitch, Blockchain Founders Fund, Hustle Fund, NGC Ventures, and strategic investors Alchemy and MoonPay. Blockchain infrastructure provider Uniblock has raised $5.2 million to operate a “managed infrastructure layer” across more than 300 blockchains, addressing a routing and failover problem that CEO Kevin Callahan said "should be solved once, not rebuilt by every team." The platform provides access to over 3,000 APIs through a single connection, with patented auto-routing handling provider selection, failover, and data normalization across 55 data partners. Named customers running production workloads include Plume Network, Stellar Blockchain, Hypernative, Oku Trade, nReach, and ApeChain, with Plume and Apechain operating Uniblock as their managed RPC infrastructure through ecosystem partnerships. The company reports 3,000 projects and 4,000 developers currently using the platform, which launched AI-native developer tools including an MCP server, LLM-optimized documentation, and agent skills for Cursor, GitHub Copilot and other AI coding environments. "We're watching two shifts happen at once. Fortune 500 companies are bringing production workloads to blockchain, and AI agents are starting to read and write chain data autonomously," Callahan said in the announcement, which noted mainstream adoption signals including Stripe's $1.1 billion acquisition of Bridge for stablecoins and prediction market odds appearing on legacy media broadcasts. Uniblocks fundraise comes amid broader industry efforts to address multi-chain infrastructure challenges, with the Ethereum Foundation backing an "Economic Zone" initiative in February to solve fragmentation issues across the ecosystem's growing number of Layer-2 networks. #VC #blockchain #crypto #layer1 #layer2 #networks https://lnkd.in/gJief25p

Congratulations to portfolio company Drata for being named #12 in the Enterprise category on Fast Company’s 2026 Most Innovative Companies List! 🚀 Adam Markowitz Troy Markowitz #enterprise #soc2 #compliance #automation

Congratulations Tim Hwang, Jonathan Chen and the entire Nitra team for raising a combined $187 million Series A and B and coming out of stealth! At AAF Management Ltd. we're proud to have been on your journey since the Seed round in 2021! 🚀 Tim Hwang has spent his career moving between politics, policy, and startups. He worked on Barack Obama’s 2008 presidential campaign, studied public policy at Princeton, and took his first company, FiscalNote, public before he turned 30. Now, at the helm of Nitra, a healthcare financial and operational platform, he’s doing what he calls “the perfect confluence of everything I’ve worked on in the past.” Nitra is an AI-native operating platform built specifically for medical practices. Rather than patching together separate tools for billing, purchasing, scheduling, and insurance verification, Nitra consolidates all of it into a single system powered by AI agents. The company targets the administrative layer of healthcare—the back-office work that consumes enormous time and costs inside clinics—and automates it end to end, from expense management and accounting to patient communications and claims filing. It is, in Hwang’s words, designed to replace the fragmented patchwork of software that most practices currently rely on just to keep the lights on. On Tuesday, Nitra announced a $50 million Series B round, bringing its total capital raised to $205 million. The funding comes alongside a milestone: the company’s platform has surpassed $1 billion in annualized processing volume and crossed $33 million in annual recurring revenue as of December 2025, representing approximately eight-fold year-over-year growth. More than 700 clinics are now live on the platform. “I think we’re probably in the first inning of our growth trajectory,” Hwang told Fortune ahead of the announcement. “I honestly believe we can get to a billion dollars in revenue in the next couple of years.” “From a business perspective, yeah, I do think Nitra is going to be a decacorn.” #fintech #healthcare #financing #VC https://lnkd.in/gNNmfR-i

Congratulations to portfolio company Dealpath and the team for a milestone 2025! Keep crushing it Mike Sroka! 🚀 #proptech #realestate #commercial

In 2025, the venture capital's market's connotation is "𝒄𝒐𝒏𝒄𝒆𝒏𝒕𝒓𝒂𝒕𝒊𝒐𝒏".  Capital continued to flow to a small number of blue-chip VC firms and leading AI firms OpenAI, Anthropic, Scale AI, xAI, and Databricks raised an estimated $67 billion contributing ~25% of the $267 billion - total dollars raised by VC-backed companies in the US in 2025! The top 10 US VC firms raised approximately $28 billion in LP commitments comprising over 42% of the $66 billion raised in total during 2025. Emerging managers operated in a tighter, more selective environment. Liquidity was constrained, underwriting standards remained elevated, and differentiation mattered more than ever. Against that backdrop, AAF Management Ltd. stayed focused on what we do best: backing exceptional early-stage founders and supporting emerging managers building durable franchises. Here are a few highlights from the year: • We closed our $55 million Fund IV, anchored by Mubadala Capital, further strengthening our long-term institutional base 💰 • We completed 3 direct investments — Marut AI, Walapay, and Hamsa — and 3 fund investments in Valyrian, Dorm Room Fund, and Anamcara, while adding 190 portfolio companies through our Axis platform 🤝🏼 • Across the portfolio, companies closed 12 financing rounds, 𝐫𝐚𝐢𝐬𝐢𝐧𝐠 𝐦𝐨𝐫𝐞 𝐭𝐡𝐚𝐧 $525 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 in follow-on capital 💵 • The firm’s AUM crossed $250 𝐦𝐢𝐥𝐥𝐢𝐨𝐧, with all vintages ranking in the top decile and Fund I, Fund II, and our first Fund-of-Funds performing in the top 10% 🔝 • Portfolio companies surpassed $1 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒊𝒏 𝒂𝒈𝒈𝒓𝒆𝒈𝒂𝒕𝒆 𝒂𝒏𝒏𝒖𝒂𝒍 𝒓𝒆𝒗𝒆𝒏𝒖𝒆, representing a 49.5% CAGR since 2017 🚀 • We published Edition II of our research series, 𝐀𝐈 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐅𝐢𝐧𝐚𝐧𝐜𝐞: 𝐀 𝐆𝐮𝐢𝐝𝐞 𝐭𝐨 𝐓𝐨𝐨𝐥𝐬 & 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬, continuing our commitment to sharing practical insights with the global investment community 📈 • Several portfolio companies, including Drata, Jasper, and Flutterwave, received major industry recognition and awards during the year 🏅 We’re proud of the progress made in a challenging market and grateful to our founders, LPs, and partners for their continued trust. We remain heads-down building a long-term franchise focused on early conviction, disciplined underwriting, and global reach. 📍 Onwards and upwards! #yearinreview2025 #venture #capital #VC

Congratulations to portfolio company Flex and its founders Zaid Rahman and Hadi Solh for closing a $60 million Series B! 🚀 Led by Portage and participation from Titanium Ventures, Wellington Management, Crosslink Capital, Spice Expeditions, LP, Companyon Ventures, Tusk Venture Partners, Florida Funders , FirstLook Partners , MS&AD Ventures, Restive Ventures, and others. At AAF Management Ltd. we are proud to have been on this rocketship over the past 2 years! "Flex is now positioned to become the category-defining private bank for HNW middle-market business owners. Our strategy to serve business owners from the time they generate revenue to the time they spend it personally is delivered through our five-pillar strategy: 1) private credit, 2) business banking, 3) private banking, 4) payments, and 5) AI ERP." #fintech #SeriesB #round #SMB #HWN #middlemarket

Portfolio company Peptilogics raises a $78 million Series B2 round The funding will support the company's Phase 2/3 pivotal trial of zaloganan (PLG0206), an investigational treatment for prosthetic joint infections (PJI). Presight Capital, Thiel Bio, and Founders Fund led the round, with participation from new investors AMR Action Fund, Narya Capital, and Beyond Ventures. This brings Peptilogics' total equity funding to approximately $120 million, along with substantial grant support from CARB-X. "What these investors understood is that hardware-related infections like PJI are different from other common infections. We chose to focus on this huge unmet need because the lack of effective therapeutic options alters the commercial landscape that has made antibiotic development difficult," said Peptilogics' CEO Jonathan Steckbeck, PhD. "Developing treatments for these infections allows us to create a new category of surgical therapeutics for patients who currently have to undergo multiple life-changing surgeries to eliminate the infection." Prosthetic joint infections are a devastating complication that can turn a successful joint replacement into a patient's worst nightmare. With 45,000 PJI cases each year in the U.S. and no approved therapeutics specifically indicated for this condition, patients face limited and often unsuccessful treatment options. Current approaches force difficult choices: implant-preserving procedures such as DAIR (debridement, antibiotics, and implant retention) have reported failure rates of approximately 50% in published literature, while grueling two-stage revision procedures require multiple surgeries, extended hospitalization, and months of disability, yet still fail 15-25% of the time. The financial burden is equally staggering, with total PJI costs often reaching more than $390,000 per patient, according to a study by Hany Bedair, MD published in Clinical Orthopedics and Related Research. "Biofilm is the common enemy and the reason why existing standard-of-care surgical interventions fail, even with systemic antibiotics," says Nick Pachuda, a former orthopedic surgeon and Peptilogics Chief Operating Officer. "Hardware-related infections are difficult to treat because bacteria on foreign surfaces hide in drug-resistant biofilm that current antibiotics cannot eliminate. Zaloganan quickly penetrates the biofilm locally and kills the hiding bacteria." In Peptilogics' Phase 1b study, zaloganan irrigation administered during DAIR procedures resulted in 13 of 14 patients (93%) remaining infection-free at 12 months. These encouraging results supported the company's decision to advance into pivotal trials. #biotech #clinical #trial #seriesB #financing #VC https://lnkd.in/ej-3sk5W

Portfolio company Current invested in Series C and D equity raises in to building its own proprietary banking core vs. acquiring users at all costs! The company generated 70% growth year-on-year and boasts 6 million members on its platform. Ten years ago, Stuart Sopp and Trevor Marshall founded Current to make banking services accessible and affordable to all Americans, especially those traditional banks were not properly serving. Some of the highest liquidity amounts in the industry: Current's earned wage access product, Paycheck Advance, offers customers access to a portion of their paychecks —up to $750 —before their scheduled paydays, without any mandatory fees. Current's Build Card: A secured charge card helping members build credit history with a single balance to view and manage on Current's platform. As members spend on the Build Card, money is set aside from their available spending balance to cover the outstanding Build Card balance. Members can set their payments to autopay, and their on-time payments are then reported to the three major credit bureaus. Members have increased their credit scores by an average of 81 points within the first six months of using the Build card. Looking ahead: Current isn't slowing down now — in fact, it's rolling out three new products to enhance the platform: Current Max, Pay Anyone and fee-free overdraft on the Build Card. Current Max is a new monthly subscription option giving eligible members who deposit their paychecks at Current 6% savings boosts, 3x points per dollar spent on dining and groceries on the Build Card, and premium support and customizable wellness benefits providing up to $40 in value for $10 per month. This is an increase from Current's already industry-leading savings boosts of up to 4%. Current Max elevates customer experience with the most value, including faster solutions from qualified agents and a larger range of benefits. Customers don't need to deposit their paychecks on Current to access Current Max, as everyone on Current can receive additional value, including premium support and the wellness benefits. Pay Anyone is a new payment feature letting members send money instantly to anyone with a phone number — extending payments beyond Current users. "There was a large request from our customers saying, 'I'd like to pay people not just on Current.' Pay Anyone means that you can now type in any phone number and pay any friend," says Sopp. Fee-free overdraft on the Build Card means eligible members can now access fee-free overdraft on their credit transactions — giving more flexibility and spending control. "Many of our customers are paycheck to paycheck, and a lot of them stay around zero between paychecks," says Sopp.” #consumer #fintech https://lnkd.in/eM4-YfZR

Congratulations to portfolio company Streetbeat for closing a $15 million Series A led by CDP Venture Capital SGR with participation from TTV Capital, Monte Carlo Capital, 3Lines Venture Capital, Azimut Group, P101 and Evolution VC. At AAF Management Ltd. we are proud to have been one of the first institutional checks in the company's Seed Round! Keep crushing it Damián Scavo! 🚀 "Streetbeat's goal is to make advanced financial intelligence accessible to everyone. Over the years, we’ve built a vertical, multi-agent AI architecture for finance capable of analysing hundreds of huge datasets and real-time market data. The platform automates many of the most complex financial processes: from portfolio creation to lead management, from market research to regulatory compliance. And let’s not forget our Next Best Action: what is the best next step you could take right now to improve your business? With Streetbeat Wealth, professionals can dramatically increase the profitability of their time and grow their AUM at a rate 5–15 % faster each year. Our data also show that with Streetbeat Retail, the solution for those who want to offer advanced AI to their customers, retention increases by 5–8 %, CAC drop by 7-11%, LTV/CAC grow double digits, and more importantly, profitability jumps, with more than 75% of investors profitable after twelve months, versus only 20 % when they trade stocks and crypto manually without AI. This funding allows us to accelerate our international expansion and double our team, with a particular focus on Italy, thanks to CDP’s impact." Check out our press release here: https://shorturl.at/JEXeQ #fintech #SeriesA #trading #

🚀 𝐁𝐢𝐠 𝐧𝐞𝐰𝐬 𝐟𝐫𝐨𝐦 𝐀𝐀𝐅! We’re thrilled to announce the close of 𝘛𝘩𝘦 𝘈𝘹𝘪𝘴 𝘍𝘶𝘯𝘥, a $55 million early-stage hybrid fund backed by Mubadala Capital. This marks the next chapter in our mission to invest in founders building generational businesses and emerging managers building multi-vintage franchises. Since our inception in 2016, AAF has evolved into a one-stop-shop capital formation and business development platform for founders and GPs seeking to access the Middle East and North Africa (MENA) and connect with global capital markets. Our firm’s two-pronged strategy—early-stage direct investing and fund-of-funds commitments to emerging managers—has allowed us to build a highly differentiated platform in today’s crowded venture ecosystem. The Axis Fund brings these strategies together into what we believe will be our best work yet. Today, we’re proud to reflect on what our journey has yielded so far 👇 💥 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 ➢ 4 funds raised since inception ➢ $250 million in Assets Under Management ➢ 138 portfolio companies across 5 continents ➢ 39 emerging managers backed across 43 fund vintages ➢ $6.35 billion total capital raised by our portfolio companies ➢ $4 billion in growth capital raised after our initial investments ➢ 80+ blue-chip VCs (each with $1B+ AUM) have led follow-on rounds in our companies 🦄 𝐏𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐈𝐦𝐩𝐚𝐜𝐭 ➢ $27B+ in aggregate enterprise value across our portfolio ➢ 5 early-stage unicorns: Jasper, Current, Flutterwave, Drata, and Hello Heart — collectively valued at over $10B ➢20 successful exits including MoneyLion, Even Financial, TruOptik, Portfolium (Acquired by Instructure), Prodigy Software Inc., betterview, Interstellar (Lightyear.io), Trim, HeyDoctor, and Medumo — representing $2B+ in combined enterprise value ➢ Exposure to 70 𝐮𝐧𝐢𝐜𝐨𝐫𝐧𝐬, 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐢𝐧𝐠 5%+ of the world’s private-market unicorns from Pre-Seed to Series E 🌍 We believe the next decade of venture capital will be defined by global connectivity, capital efficiency, and cross-border collaboration—and 𝘛𝘩𝘦 𝘈𝘹𝘪𝘴 𝘍𝘶𝘯𝘥 is built precisely for that. By bridging sovereign and institutional capital with frontier innovation across the U.S. and beyond, we aim to catalyze the next wave of category-defining companies that transcend borders and industries. A heartfelt thank you to our partners, LPs, founders, and the incredible global community that has supported our vision from day one! Check out: 🔗 Our interview in TechCrunch https://lnkd.in/epNRZvHr 🔗 🔗 Our interview in Forbes https://lnkd.in/esWcdHzs 🔗 Onward and upward! 🚀 Omar Darwazah Kyle Hendrick Saud H. A. Evan Hendrick Omar Allabadi #fundraise #newfund #venturecapital #earlystage #emergingmanagers